Skip to main content
NCBI home page
Gut logoLink to Gut
. 1992 Oct;33(10):1381–1385. doi: 10.1136/gut.33.10.1381

Factors related to early mortality in cirrhotic patients bleeding from varices and treated by urgent sclerotherapy.

O Le Moine 1, M Adler 1, N Bourgeois 1, M Delhaye 1, J Devière 1, M Gelin 1, A Vandermeeren 1, A Van Gossum 1, A Vereerstraeten 1, P Vereerstraeten 1, et al.
PMCID: PMC1379608  PMID: 1446864

Abstract

Variceal haemorrhage in cirrhotic patients carries a high early mortality even when balloon tamponade or emergency sclerotherapy are applied. The aim of this study to identify patients dying within six weeks of their first variceal haemorrhage. One hundred and twenty one patients with parenchymal cirrhosis presenting with the first variceal bleeding episode between June 1983 and December 1988 were studied. Nineteen patients were excluded for various reasons. Emergency sclerotherapy was carried out in cases of active bleeding or where there were endoscopic signs of recent bleeding, and then regularly repeated afterwards. Of the 24 variables studied and included in a multivariate analysis using a logistic regression model, three had an independent prognostic value: encephalopathy, prothrombin time, and the number of blood units transfused within the 72 hours of time zero. The subsequent regression equation was able to predict 89% of the patients who will die and 97% of the patients who will still be alive six weeks after their first variceal haemorrhage treated by sclerotherapy. Pugh score was less discriminatory than these last three variables in terms of accuracy of adjustment, goodness of fit to the model, receiver operating characteristic curves, and percentage correct prediction. To measure the accuracy of the prediction rule, our model was applied to another series of 28 cirrhotic patients admitted with their first variceal bleeding during the next period (January 1989 to May 1990). Death and survival were correctly predicted in respectively 82% and 94% of the cases. The use of this score is recommended for the selection of patients with high early mortality after variceal bleeding despite sclerotherapy, and for the design of new therapeutic trials.

Full text

PDF
1381

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burroughs A. K., D'Heygere F., McIntyre N. Pitfalls in studies of prophylactic therapy for variceal bleeding in cirrhotics. Hepatology. 1986 Nov-Dec;6(6):1407–1413. doi: 10.1002/hep.1840060631. [DOI] [PubMed] [Google Scholar]
  2. Burroughs A. K., Hamilton G., Phillips A., Mezzanotte G., McIntyre N., Hobbs K. E. A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med. 1989 Sep 28;321(13):857–862. doi: 10.1056/NEJM198909283211303. [DOI] [PubMed] [Google Scholar]
  3. Burroughs A. K., Mezzanotte G., Phillips A., McCormick P. A., McIntyre N. Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates. Hepatology. 1989 Jun;9(6):801–807. doi: 10.1002/hep.1840090602. [DOI] [PubMed] [Google Scholar]
  4. Buset M., Des Marez B., Baize M., Bourgeois N., Cremer M. Bleeding esophagogastric varices: an endoscopic study. Am J Gastroenterol. 1987 Mar;82(3):241–244. [PubMed] [Google Scholar]
  5. Calès P., Pascal J. P. Histoire naturelle des varices oesophagiennes au cours de la cirrhose (de la naissance à la rupture). Gastroenterol Clin Biol. 1988 Mar;12(3):245–254. [PubMed] [Google Scholar]
  6. Christensen E., Krintel J. J., Hansen S. M., Johansen J. K., Juhl E. Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis. Survival and prognostic factors. Scand J Gastroenterol. 1989 Oct;24(8):999–1006. doi: 10.3109/00365528909089247. [DOI] [PubMed] [Google Scholar]
  7. Garden O. J., Motyl H., Gilmour W. H., Utley R. J., Carter D. C. Prediction of outcome following acute variceal haemorrhage. Br J Surg. 1985 Feb;72(2):91–95. doi: 10.1002/bjs.1800720205. [DOI] [PubMed] [Google Scholar]
  8. Ginés P., Quintero E., Arroyo V., Terés J., Bruguera M., Rimola A., Caballería J., Rodés J., Rozman C. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987 Jan-Feb;7(1):122–128. doi: 10.1002/hep.1840070124. [DOI] [PubMed] [Google Scholar]
  9. Graham D. Y., Smith J. L. The course of patients after variceal hemorrhage. Gastroenterology. 1981 Apr;80(4):800–809. [PubMed] [Google Scholar]
  10. Hosking S. W., Johnson A. G. Gastric varices: a proposed classification leading to management. Br J Surg. 1988 Mar;75(3):195–196. doi: 10.1002/bjs.1800750303. [DOI] [PubMed] [Google Scholar]
  11. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  12. McNeil B. J., Keller E., Adelstein S. J. Primer on certain elements of medical decision making. N Engl J Med. 1975 Jul 31;293(5):211–215. doi: 10.1056/NEJM197507312930501. [DOI] [PubMed] [Google Scholar]
  13. Melchior J. C., Poupon R. E., Verrier J., Merrer J., Moncorge C., Simon N. Analyse des facteurs liés à la mortalité précoce au cours des hémorragies digestives dues à l'hypertension portale. Gastroenterol Clin Biol. 1987 May;11(5):402–408. [PubMed] [Google Scholar]
  14. Orrego H., Israel Y., Blake J. E., Medline A. Assessment of prognostic factors in alcoholic liver disease: toward a global quantitative expression of severity. Hepatology. 1983 Nov-Dec;3(6):896–905. doi: 10.1002/hep.1840030602. [DOI] [PubMed] [Google Scholar]
  15. Paquet K. J. Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial. Endoscopy. 1982 Jan;14(1):4–5. doi: 10.1055/s-2007-1021560. [DOI] [PubMed] [Google Scholar]
  16. Poynard T., Chaput J. C., Mary J. Y., Scolaro M., Buffet C., Etienne J. P. Analyse critique des facteurs liés à la mortalité au trentième jour dans les hémorragies digestives hautes du cirrhotique. Gastroenterol Clin Biol. 1980 Oct;4(10):655–665. [PubMed] [Google Scholar]
  17. Prindiville T., Miller M., Trudeau W. Prognostic indicators in acute variceal hemorrhage after treatment by schlerotherapy. Am J Gastroenterol. 1987 Jul;82(7):655–659. [PubMed] [Google Scholar]
  18. Pugh R. N., Murray-Lyon I. M., Dawson J. L., Pietroni M. C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973 Aug;60(8):646–649. doi: 10.1002/bjs.1800600817. [DOI] [PubMed] [Google Scholar]
  19. Ramond M. J., Valla D., Mosnier J. F., Degott C., Bernuau J., Rueff B., Benhamou J. P. Successful endoscopic obturation of gastric varices with butyl cyanoacrylate. Hepatology. 1989 Oct;10(4):488–493. doi: 10.1002/hep.1840100415. [DOI] [PubMed] [Google Scholar]
  20. Sauerbruch T., Weinzierl M., Köpcke W., Paumgartner G. Long-term sclerotherapy of bleeding esophageal varices in patients with liver cirrhosis. An evaluation of mortality and rebleeding risk factors. Scand J Gastroenterol. 1985 Jan;20(1):51–58. doi: 10.3109/00365528509089632. [DOI] [PubMed] [Google Scholar]
  21. Stiegmann G. V., Goff J. S., Sun J. H., Davis D., Bozdech J. Endoscopic variceal ligation: an alternative to sclerotherapy. Gastrointest Endosc. 1989 Sep-Oct;35(5):431–434. doi: 10.1016/s0016-5107(89)72850-9. [DOI] [PubMed] [Google Scholar]
  22. Witzel L., Wolbergs E., Merki H. Prophylactic endoscopic sclerotherapy of oesophageal varices. A prospective controlled study. Lancet. 1985 Apr 6;1(8432):773–775. doi: 10.1016/s0140-6736(85)91444-8. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES